Cargando…
Erratum for Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II
Autores principales: | Izutsu, Takuma, Ito, Hiroyuki, Fukuda, Izumi, Tamura, Hideki, Matsumoto, Suzuko, Antoku, Shinichi, Mori, Toshiko, Goto, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263188/ https://www.ncbi.nlm.nih.gov/pubmed/34135269 http://dx.doi.org/10.2169/internalmedicine.E003-21 |
Ejemplares similares
-
Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II
por: Izutsu, Takuma, et al.
Publicado: (2020) -
Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin
por: Ito, Hiroyuki, et al.
Publicado: (2023) -
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation
por: Ito, Hiroyuki, et al.
Publicado: (2021) -
Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2019) -
Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study
por: Ito, Hiroyuki, et al.
Publicado: (2022)